---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-004019"
form_type: "8-K"
ticker: "CRVS"
cik: "0001626971"
company_name: "Corvus Pharmaceuticals, Inc."
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:03:13.005697+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Corvus Pharmaceuticals holds 2023 annual meeting; elects directors and ratifies auditor

## Summary
- Stockholders elected Richard A. Miller, M.D. and Linda S. Grais, M.D., J.D. as Class I directors for three-year terms.
- Ratified PricewaterhouseCoopers as independent auditor for FY2023 with 35.9M votes for, 0.1M against.
- Non-binding advisory vote on executive compensation passed with 25.6M for, 0.4M against.
- Total shares voted: 36.2M of 46.6M outstanding (77.6% turnout).

## SEC filing metadata
- accession: 0001171843-23-004019
- form_type: 8-K
- ticker: CRVS
- cik: 0001626971
- company_name: Corvus Pharmaceuticals, Inc.
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/f8k_062023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-004019
- JSON: https://secwatch.observer/filing/0001171843-23-004019.json
- Plain text: https://secwatch.observer/filing/0001171843-23-004019.txt

## Key facts
- Shareholder Votes
  Corvus Pharmaceuticals, Inc. shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2023-06-15 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Votes For Votes Against Abstain Broker Non-Votes 25,550,695 348,929 177,941 10,073,471
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm
- Shareholder Votes
  Corvus Pharmaceuticals, Inc. shareholders approved Ratification of selection of PricewaterhouseCoopers LLC as independent registered accounting firm at the 2023-06-15 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Votes For Votes Against Abstain 35,873,795 104,973 172,268
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm
- Shareholder Votes
  Corvus Pharmaceuticals, Inc. shareholders approved Election of Class I directors at the 2023-06-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Class I Director Nominees Votes For Votes Withheld Broker Non-Votes Richard A. Miller, M.D. 26,009,538 68,027 10,073,471 Linda S. Grais, M.D. J.D. 25,210,111 867,454 10,073,471
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.